Jury Deliberates on New England Compounding Murder Charges

A federal jury is slated to begin deliberating tomorrow in the trial of Barry J. Cadden, the former New England Compounding Center head pharmacist who is accused of causing the 2012 fungal meningitis outbreak that killed 64 people.
March 14, 2017

A federal jury is slated to begin deliberating tomorrow in the trial of Barry J. Cadden, the former New England Compounding Center head pharmacist and co-owner who is accused of causing the 2012 fungal meningitis outbreak that killed 64 people.

According to Law360, prosecutors allege that Cadden committed 25 counts of second-degree murder by skipping sterility tests, ignoring troubling environmental results and making drugs with long-expired ingredients, leading to the contamination of injectable steroids with mold.

Cadden is also being accused of defrauding the FDA by pretending that the New England Compounding Center was a pharmacy rather than a drug manufacturer.

Read the Boston Globe coverage

Sign up for Pharma Manufacturing Newsletters
Get the latest news and updates